Results 1 to 10 of about 111 (77)

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers. [PDF]

Adv Sci (Weinh), 2023
Pten and p53 are the most frequently mutated tumor suppressor genes in endometrial carcinomas. New technical approaches such as in vivo TAT‐Cre delivery, in vivo CRISPR/Cas9 editing, xenotransplantation or organoids unveiled pathological outcome of loss of Pten/p53 ablation.
Navaridas R, Vidal-Sabanés M, Ruiz-Mitjana A, Ruiz-Mitjana A, Altés G, Perramon-Güell A, Yeramian A, Egea J, Encinas M, Gatius S, Matias-Guiu X, Dolcet X.   +11 more
europepmc   +2 more sources

Abstract Book for the 27th Congress of the European Hematology Association [PDF]

Hemasphere, 2022
HemaSphere, Volume 6, Issue S3, Page 1-4130, June 2022.
europepmc   +2 more sources

Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020 [PDF]

Hemasphere, 2020
HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
europepmc   +2 more sources

UEG Week 2024 Poster Presentations [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 12, Issue S8, Page 665-1360, October 2024.
europepmc   +2 more sources

PB1844 SUCCESSFUL TREATMENT OF 5 PATIENTS WITH ACQUIRED HEMOPHILIA WITH HIGH INHIBITOR TITER ‐ SINGLE CENTER SURVEY

HemaSphere, Volume 3, Issue S1, Page 842-843, June 2019., 2019
Background: Acquired hemophilia A (AHA) is a rare, severe and potentially life treating bleeding disorder. It is caused by the spontaneously formed autoantibodies, which are polyclonal immunoglobulins, usually IgG directed against the FVIII. While this disorder may appear at any age, the elderly are most commonly affected.
M. Dragičević Jojkić, N. Rajić, A. El Farra, I. Urošević   +3 more
wiley   +1 more source

PB1845 THE EFFICACY OF TRANEXAMIC ACID IN MINOR SURGERY WITH BLEEDING DISORDERS PATIENTS: 17 YEARS EXPERIENCE AT UNIVERSITY HOSPITAL

HemaSphere, Volume 3, Issue S1, Page 843, June 2019., 2019
Background: Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce blood loss in different medical disorders. Aims: To assess the efficacy and outcome to use TXA in dental work with patient with bleeding disorders at our institute over 17 years period.
S. Al Jaouni, D. Farsi, S. Al Muhayawi
wiley   +1 more source

PB1846 ANTHROPOMETRIC AND HORMONAL PARAMETERS IN COMPARISON WITH BONE MINERAL DENSITY IN MEN WITH HAEMOPHILIA FROM LOWER SILESIA ‐ PRELIMINARY REPORT

HemaSphere, Volume 3, Issue S1, Page 843, June 2019., 2019
Background: In patients with haemophilia, recurrent episodes of bleeding lead to joint deterioration and bone resorption. To date, the effect of various risk factors on the bone mineral density (BMD) reduction have found conflicting results. Aims: The aim of the study was to analyze the impact of certain parameters, such as: viral status of patients ...
M.M. Biernat, D. Jędrzejuk, D. Urbaniak‐Kujda, I. Prajs, M. Podolak‐Dawidziak, T. Wróbel   +5 more
wiley   +1 more source

PB1847 CONGENITAL COMBINED DEFECTS OF COAGULATION FACTORS FVII AND FX: ABOUT A TUNISIAN FAMILY.

HemaSphere, Volume 3, Issue S1, Page 843-844, June 2019., 2019
Background: Combined factor VII (FVII) and factor X (FX) deficiency is considered as an extremely rare bleeding disorder. Only a few cases have been reported all over the world. According to the WFH (World Federation of Hemophilia) 2014, the global populations’ prevalence of combined defects of coagulation factors (CDCF) is close to 1:2 000 000.
S. Maalej, F. Megdiche, M. Ghorbel, S. Kacem, O. Kassar, Y. Fakhfakh, F. Kotti, H. Chaabane, L. Mbarek, M. Elloumi, C. Kallel   +10 more
wiley   +1 more source

UEG Week 2017 Poster Presentations

, 2017
United European Gastroenterology Journal, Volume 5, Issue S5, Page A161-A836, October 2017.
wiley   +1 more source

UEG Week 2014 Poster Presentations

, 2014
United European Gastroenterology Journal, Volume 2, Issue S1, Page A132-A605, October 2014.
wiley   +1 more source